6-7 NEWS
Gilead acquires CymaBay for $4.3bn; AstraZeneca gets FDA approval for advanced lung cancer

8-9 NEWS
AbbVie’s Parkinson’s drug made available by NHS England; Sanofi’s frexalimab shows promise in MS

10-11 DERMATOLOGY NEWS
FDA approves Iovance’s Amtagvi for advanced melanoma; Pfizer’s Litfulo recommended by NICE

12 DARWIN'S MEDICINE
The anthropologists’ advantage

13 POLICY AND PUBLIC HEALTH
Healthcare costs in the US – till debt do us part

14 THE WHYS AND WHATS OF PROFESSIONAL ASSOCIATIONS
The benefits of joining your sector’s group

15 INNOVATIVE IMPACT BLOG
Finding new approaches to delivering traditional services in novel ways

16-17 WOMEN IN PHARMA
This month PME spoke to Rippon Ubhi, Country Lead for Sanofi UK & Ireland, about her new role

19 LIFE SCIENCES SECTOR EXPANDS IN LIVERPOOL
The region’s new Investment Zone is expected to supercharge health and life sciences

20-21 ENHANCING COLLABORATIVE DECISION-MAKING
Matias Ferraris, head of International Medical Affairs at Novartis Neuroscience, looks at the importance of optimising care for MS patients

24-25 THE THREAT OF AMR
In the face of the increasing threat from AMR, the recent Bioinfect 2024 conference offers five reasons to be hopeful

26-27 THE BATTLE AGAINST COUNTERFEIT DRUGS
PME spoke to Remi Turbet Delof about the recent rise in drug counterfeiting and navigating the complex world of serialisation

28-29 HEADWINDS LOOM FOR PHARMA WEB STRATEGY
How to best respond to what 30 years ago was still the World Wide Web remains a question that has yet to be wholly answered. The industry has some pressing new challenges to face in the web space, but many companies also have yet to confront some legacy issues

30-32 THE KILLER QUESTION
Expert strategists ask four crucial questions – the first one confounds most of us

33 CAMBRIDGE’S GRAFTON CENTRE TO BE DEVELOPED INTO LAB AND OFFICE SPACE
Expert strategists ask four crucial questions – the first one confounds most of us

37 HEALTHCARE COMMS
Real Chemistry acquires Avant Healthcare to boost HCP messaging capabilities; Helios acquires HEOR and market access firm Cogentia

March 2024